Journal of Clinical Immunology

, Volume 1, Issue 4, pp 262–265 | Cite as

Altered leukocyte chemiluminescence during hemodialysis

  • Lawrence S. Wissow
  • Raymond S. Greenberg
  • Richard O. Burns
  • Stephen G. Osofsky
  • Robert A. Gutman
  • Patricia J. Baker
Short Communication


The chemiluminescent response of leukocytes collected 30 min into hemodialysis was reduced to one-third that of autologous predialysis cells. The reduction was transient, with chemiluminescence returning to predialysis values by 2 hr. The dialysis procedure also caused slight C3 conversion as well as a reduction of alternative pathway hemolytic titer.

Key words

Hemodialysis chemiluminescence complement 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kaslow RA, Zellmer SR: Infection in patients on maintenance hemodialysis. Lancet 2:117–118, 1972Google Scholar
  2. 2.
    Leonard A, Raij L, Shapiro FL: Bacterial endocarditis in regularly dialyzed patients. Kidney Int 4:407–422, 1973Google Scholar
  3. 3.
    Montgomerie JZ, Kalmanson GM, Guze LB: Renal failure and infection. Medicine 47:1–32, 1968Google Scholar
  4. 4.
    Peterson PK, Verhoef J, Sabath LD, Quie PG: Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun 14:496–501, 1976Google Scholar
  5. 5.
    Wheat LJ, Humphreys DW, White A: Opsonization of staphylococci by normal human sera: The role of antibody and heat-labile factors. J Lab Clin Med 83:73–78, 1974Google Scholar
  6. 6.
    Kaplow LS, Goffinet JA: Profound neutropenia during the early phase of hemodialysis. JAMA 203:1135–7, 1968Google Scholar
  7. 7.
    Brubaker LH, Nolph KD: Mechanisms of recovery from neutropenia induced by hemodialysis. Blood 38:623–631, 1971Google Scholar
  8. 8.
    Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296:769–774, 1977Google Scholar
  9. 9.
    Allen RC, Yevich SJ, Ortho RW, Steele RH: The superoxide anion and singlet molecular oxygen: Their role in the microbicidal activity of the polymorphonuclear leukocyte. Biochem Biophys Res Commun 60:909–913, 1974Google Scholar
  10. 10.
    Hemming VG, Hall RT, Rhodes PG, Shigeoka RO, Hill HR: Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest 58:1379–1387, 1976Google Scholar
  11. 11.
    Stjernholm RL, Allen RC, Steele RH, Warring WW, Harris JA: Impaired chemiluminescence during phagocytosis of opsonized bacteria. Infect Immun 7:313–314, 1973Google Scholar
  12. 12.
    Allen RC: Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes. Infect Immun 15:828–833, 1977Google Scholar
  13. 13.
    Baker PJ, Osofsky SG: Activation of human complement by heat-killed, human kidney cells grown in cell culture. J Immunol 124:81–86, 1980Google Scholar
  14. 14.
    Henderson LW, Miller ME, Hamilton RW, Norman ME: Hemodialysis leukopenia and polymorph random mobility—a possible correlation. J Lab Clin Med 85:191–197, 1975Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • Lawrence S. Wissow
    • 1
  • Raymond S. Greenberg
    • 2
  • Richard O. Burns
    • 1
  • Stephen G. Osofsky
    • 2
  • Robert A. Gutman
    • 3
  • Patricia J. Baker
    • 1
    • 2
  1. 1.Department of MicrobiologyDuke University Medical CenterDurham
  2. 2.Department of PediatricsDuke University Medical CenterDurham
  3. 3.Department of MedicineDuke University and the Durham Veterans Administration Medical CentersDurham

Personalised recommendations